Pharmanutra S.p.A. (FRA:761)
Germany
· Delayed Price · Currency is EUR 56.40
-0.60 (-1.05%)
At close: Dec 4, 2025
Pharmanutra Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 525 | 523 | 542 | 601 | 730 | 364 | Upgrade
|
| Market Cap Growth | 1.62% | -3.62% | -9.76% | -17.67% | 100.53% | 60.68% | Upgrade
|
| Enterprise Value | 524 | 523 | 552 | 595 | 710 | 350 | Upgrade
|
| Last Close Price | 55.80 | 52.91 | 54.16 | 59.69 | 70.12 | - | Upgrade
|
| PE Ratio | 30.11 | 31.47 | 42.26 | 39.94 | 53.01 | 25.87 | Upgrade
|
| PS Ratio | 4.13 | 4.50 | 5.39 | 7.24 | 10.71 | 6.41 | Upgrade
|
| PB Ratio | 7.95 | 8.40 | 9.97 | 11.80 | 16.19 | 9.65 | Upgrade
|
| P/TBV Ratio | 12.60 | 12.79 | 16.38 | 19.87 | 18.30 | 11.18 | Upgrade
|
| P/FCF Ratio | 50.39 | 32.16 | - | - | 47.32 | 35.98 | Upgrade
|
| P/OCF Ratio | 36.36 | 25.50 | 44.85 | 34.41 | 35.76 | 30.85 | Upgrade
|
| EV/Sales Ratio | 4.12 | 4.50 | 5.49 | 7.16 | 10.41 | 6.17 | Upgrade
|
| EV/EBITDA Ratio | 16.56 | 17.29 | 21.72 | 24.56 | 36.76 | 23.19 | Upgrade
|
| EV/EBIT Ratio | 18.61 | 19.11 | 24.00 | 25.78 | 38.78 | 24.71 | Upgrade
|
| EV/FCF Ratio | 50.30 | 32.17 | - | - | 46.00 | 34.61 | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.39 | 0.52 | 0.35 | 0.14 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.66 | 0.79 | 1.10 | 0.73 | 0.33 | 0.11 | Upgrade
|
| Debt / FCF Ratio | 2.01 | 1.49 | - | - | 0.41 | 0.16 | Upgrade
|
| Asset Turnover | 1.08 | 1.01 | 0.95 | 0.97 | 1.11 | 1.13 | Upgrade
|
| Inventory Turnover | 6.81 | 7.53 | 7.76 | 10.13 | 15.13 | 16.15 | Upgrade
|
| Quick Ratio | 1.60 | 1.95 | 1.70 | 1.96 | 3.08 | 3.39 | Upgrade
|
| Current Ratio | 2.19 | 2.38 | 2.12 | 2.28 | 3.32 | 3.63 | Upgrade
|
| Return on Equity (ROE) | 27.73% | 28.39% | 24.36% | 31.34% | 33.26% | 42.73% | Upgrade
|
| Return on Assets (ROA) | 14.96% | 14.88% | 13.54% | 16.82% | 18.58% | 17.61% | Upgrade
|
| Return on Capital (ROIC) | 20.67% | 20.25% | 19.05% | 24.01% | 25.18% | 23.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 31.80% | 30.40% | 27.20% | 31.00% | 33.50% | 34.90% | Upgrade
|
| Earnings Yield | 3.32% | 3.18% | 2.37% | 2.50% | 1.89% | 3.87% | Upgrade
|
| FCF Yield | 1.98% | 3.11% | -0.21% | -1.45% | 2.11% | 2.78% | Upgrade
|
| Dividend Yield | 1.75% | 1.89% | 1.57% | 1.34% | 1.01% | - | Upgrade
|
| Payout Ratio | 54.97% | 49.20% | 60.11% | 45.53% | 47.10% | 31.64% | Upgrade
|
| Buyback Yield / Dilution | 0.58% | 0.61% | 0.05% | 0.09% | - | - | Upgrade
|
| Total Shareholder Return | 2.33% | 2.50% | 1.62% | 1.43% | 1.01% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.